Clinical Trial Update: Digoxin and Senolysis in Heart Failure and Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating digoxin and senolysis for heart failure with reduced ejection fraction and type 2 diabetes mellitus; the study status is not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction
• Type 2 Diabetes Mellitus

Drugs mentioned

• DIGOXIN (Digoxin)
• Senolysis

Snippet

Sponsor: University of Leeds | Conditions: Heart Failure, Systolic, Diabetes Mellitus, Type 2 | Phase 2 | Status: NOT_YET_RECRUITING